Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-701-3 | CAS number: 1003-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro:
The mutagenic potential of n-Pentenoxide-1,2 was analyzed similar to OECD guideline 471 in the bacterial Ames test (control with E. coli or S. typhimurium TA 102 strain is missing). The test item was applied up to the highest concentration of 5000 µg/plate. No changes in bacterial cell growth was observed in the strains TA98 and TA1537. However, a slight increase in revertant colonies was observed in the TA100 S. typhimurium (1.6 -fold increase without and 1.7 -fold increase with metabolic activation at the highest concentration; no changes at lower concentration) and a significant dose-dependent increase in the TA1535 strain (2.3 -fold without and 2 -fold with metabolic activation at 5000 µg/plate). These results indicate that n-Pentenoxide-1,2 is weakly mutagenic in the Ames test under the applied experimental conditions. According to this result, the mutagenic potential of n-Pentenoxide-1,2 was investigated in the Luria and Delbrück's fluctuation test using Klebsiella pneumoniae as test organism. The test item was dissolved in DMSO and subsequently added to Broth which was inoculated with a mutant of Klebsiella pneumoniae requiring uracil and proline for growth. If an increase of the mutation rate compared to the spontaneous mutation rate by 1.5 or more was observed, the test substance was considered to be mutagenic. Increased mutation rates as compared to the control were observed following incubation with 86 mg/l (2.3 -fold), 172 mg/L (2.6 -fold) and 430 mg/l (3.2 -fold) of the test item. Hence, n-Pentenoxide-1,2 also showed a mutagenic potential in this test.
Apart from n-Pentenoxide-1,2, 1,2 -Butenoxide did also show a mutagenic potential in a variety of in vitro studies. In particular, 1,2 -Butenoxide showed a weakly mutagenic effect in the Ames test (OECD guideline 471) when tested in concentrations ranging from 20 - 7500 ug/plate with and without S-9 mix in all Salmonalle typhimurium strains analysed (TA1535, 1537, 98 and 100; BASF, 1989). Furthermore, Anderson et al. (1990) reported a positive result for the chromosome aberration test with Chinese hamster ovary cell with and without S-9 mix at the highest dose of 1,2 -Butenoxide (500 ug/ml). Moreover, McGregor et al. (1987) found a positive result for 1,2 -Butenoxide with and without S-9 mix in a mammalian gene mutation assay with mouse lymphoma L5178Y cells. These results further support the validity of a read-across between these two epoxides, suggesting that both compounds possess an in vitro mutagenic capacity.
The only structural difference between n-Pentenoxid-1,2 and 1,2-Butenoxide is the presence of an additional CH2 -group in n-Pentenoxide-1,2. The chemical characteristics between these two substances are quite similar, with 1,2 -Butenoxide being more soluble in water (86.6 g/L vs 23 g/L water solubility) and less lipophilic (log Pow=0.68 vs 1.29) and exhibiting a higher vapor pressure (227 hPa vs 70 hPa) as compared with n-Pentenoxide-1,2. It has been shown that the toxicities of epoxides decrease from ethylenoxide to propylenoxide to 1,2-Butenoxide, suggesting that the toxicity of this reactive group of epoxide chemicals decreases with increasing length of the carbon backbone (Fox et al, 1983; NTP report No 267, 1985).
In vivo:
In vivo results for n-Pentenoxide-1,2 are not available. However, as mentioned above, the in vivo mutagenic potential can be derived from experimental data of the closely related 1,2 -Butenoxide, for which negative results have been reported in an chromosome aberration assay (OECD guideline 475). The test substance was given via inhalation (7 single exposures for 5 consecutive days) to male and female rats at concentrations of 250 and 1000 ppm (NIOSH, 1981). Furthermore, in a dominant-lethal test (NIOSH, 1981) according to OECD guideline 478, 1,2 -Butenoxide had no identifiable effect on male rats when given in doses of 250 and 1000 ppm via inhalation (vapor). These data suggest that even though 1,2 -Butenoxide and n-Pentenoxide-1,2 have mutagenic capacity in vitro, they lack clastogenic activity in vivo.
1,2 -Butenoxide is legally classified as cancer category 2 according to Regulation (EC) 1272/2008, but lacks classification for genetic toxicity. Accordingly, n-Pentenoxide-1,2 will follow also be classified as potential carcinogen (cancer Cat 2), but no label will be used concerning genotoxicity.
Short description of key information:
mutagenic in bacteria (BASF AG, 1989; Ames test (OECD471); Voogd et al, Luri and Delbruecks fluctuation test, 1981)
Read-across to 1,2-Butenoxide: negative in vivo results in the chromosome aberration test (OECD475) and dominant lethal test (OECD478; NIOSH, 1981)
Endpoint Conclusion:
Justification for classification or non-classification
The mutagenic effects found in vitro could not be confirmed in in vivo studies for 1,2 -Butenoxide, a stuctural analog of n-Pentenoxid-1,2; gonadic tissues are not affected. These results indicate that the test substance is unlikely to exert systemic effects, but rather induces local genetic alterations. Hence, classification is not warranted according to Directive 67/548/EEC and Regulation (EC) 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.